优化参数对直接可交付的帕雷托前线的影响,用于前列腺癌的探索
Diana Wüthrich1, Michele Zeverino1, Jean Bourhis2
1Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Rue du Grand-Pré 1, CH-1007 Lausanne, Switzerland.
概括
在前列腺癌放射治疗中,围绕计划目标体积 (PTV) 和膀平均剂量的剂量梯度显著影响治疗优化. 这些因素对于在反向规划中实现最佳的帕雷托前线至关重要.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 计算生物学 计算生物学
背景情况:
- 反向放射治疗治疗规划包括优化辐射输送到瘤的目标,同时尽量减少剂量到周围的健康组织.
- 巴雷托阵线代表了竞争目标之间的最佳权衡,例如最大限度地提高瘤覆盖率和最大限度地降低风险器官 (OAR) 剂量.
- 了解各种优化参数在帕雷托方面的影响对于临床决策至关重要.
研究的目的:
- 研究不同优化参数在前列腺癌逆辐射治疗计划中的临床相关性.
- 为了确定哪些参数最显著地影响帕雷托前线,代表最佳的处理解决方案.
主要方法:
- 开发了一个内部的Python脚本来控制RayStation处理计划系统,用于计算可直接交付的帕雷托前线.
- 通过改变计划目标体积 (PTV) 覆盖率和OAR剂量 (直肠,膀,股骨头) 来计算参考帕雷托前线.
- 使用临床距离测量来评估参数影响的不同帕雷托前线进行比较.
主要成果:
- 验证了Python脚本,以便在2D和3D中进行准确的帕雷托前方计算.
- 确定帕雷托前线受到客观功能和固定的OAR剂量的影响.
- 确定PTV周围的剂量梯度,PTV目标功能重量和膀平均剂量是临床相关差异最有影响力的参数.
结论:
- 围绕PTV的剂量梯度和平均膀剂量是前列腺外束放射治疗多标准优化的关键参数.
- 这些发现有助于完善反向规划策略,以提高治疗效率和减少毒性.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
297
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
相关概念视频
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
